vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and HORIZON BANCORP INC (HBNC). Click either name above to swap in a different company.
HORIZON BANCORP INC is the larger business by last-quarter revenue ($63.5M vs $62.1M, roughly 1.0× Cytek Biosciences, Inc.). HORIZON BANCORP INC runs the higher net margin — 42.4% vs -70.9%, a 113.3% gap on every dollar of revenue. On growth, HORIZON BANCORP INC posted the faster year-over-year revenue change (19.5% vs 8.1%). HORIZON BANCORP INC produced more free cash flow last quarter ($74.3M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 9.2%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.
CTKB vs HBNC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $63.5M |
| Net Profit | $-44.1M | $26.9M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 51.5% |
| Net Margin | -70.9% | 42.4% |
| Revenue YoY | 8.1% | 19.5% |
| Net Profit YoY | -557.1% | 347.4% |
| EPS (diluted) | — | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $63.5M | ||
| Q3 25 | $52.3M | $58.4M | ||
| Q2 25 | $45.6M | $66.3M | ||
| Q1 25 | $41.5M | $68.8M | ||
| Q4 24 | $57.5M | $53.1M | ||
| Q3 24 | $51.5M | $58.4M | ||
| Q2 24 | $46.6M | $55.8M | ||
| Q1 24 | $44.9M | $53.2M |
| Q4 25 | $-44.1M | $26.9M | ||
| Q3 25 | $-5.5M | $-222.0M | ||
| Q2 25 | $-5.6M | $20.6M | ||
| Q1 25 | $-11.4M | $23.9M | ||
| Q4 24 | $9.6M | $-10.9M | ||
| Q3 24 | $941.0K | $18.2M | ||
| Q2 24 | $-10.4M | $14.1M | ||
| Q1 24 | $-6.2M | $14.0M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 51.5% | ||
| Q3 25 | -17.6% | -490.4% | ||
| Q2 25 | -23.3% | 36.8% | ||
| Q1 25 | -36.1% | 40.8% | ||
| Q4 24 | 5.2% | -41.3% | ||
| Q3 24 | -8.2% | 31.0% | ||
| Q2 24 | -18.3% | 28.5% | ||
| Q1 24 | -23.9% | 28.8% |
| Q4 25 | -70.9% | 42.4% | ||
| Q3 25 | -10.5% | -380.2% | ||
| Q2 25 | -12.2% | 31.1% | ||
| Q1 25 | -27.5% | 34.8% | ||
| Q4 24 | 16.8% | -20.5% | ||
| Q3 24 | 1.8% | 31.1% | ||
| Q2 24 | -22.4% | 25.4% | ||
| Q1 24 | -13.8% | 26.3% |
| Q4 25 | — | $0.44 | ||
| Q3 25 | — | $-4.69 | ||
| Q2 25 | — | $0.47 | ||
| Q1 25 | — | $0.54 | ||
| Q4 24 | — | $-0.25 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $0.32 | ||
| Q1 24 | — | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $139.5M |
| Total DebtLower is stronger | — | $248.6M |
| Stockholders' EquityBook value | $341.7M | $688.3M |
| Total Assets | $461.5M | $6.4B |
| Debt / EquityLower = less leverage | — | 0.36× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $139.5M | ||
| Q3 25 | $93.3M | $458.3M | ||
| Q2 25 | $75.5M | $137.9M | ||
| Q1 25 | $95.3M | $169.7M | ||
| Q4 24 | $98.7M | $293.4M | ||
| Q3 24 | $162.3M | $234.8M | ||
| Q2 24 | $177.9M | $146.1M | ||
| Q1 24 | $168.8M | — |
| Q4 25 | — | $248.6M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | $688.3M | ||
| Q3 25 | $378.6M | $660.8M | ||
| Q2 25 | $377.6M | $790.9M | ||
| Q1 25 | $379.6M | $776.1M | ||
| Q4 24 | $395.7M | $763.6M | ||
| Q3 24 | $385.5M | $754.8M | ||
| Q2 24 | $389.1M | $726.7M | ||
| Q1 24 | $392.6M | $721.3M |
| Q4 25 | $461.5M | $6.4B | ||
| Q3 25 | $494.9M | $6.7B | ||
| Q2 25 | $493.3M | $7.7B | ||
| Q1 25 | $482.6M | $7.6B | ||
| Q4 24 | $499.5M | $7.8B | ||
| Q3 24 | $491.2M | $7.9B | ||
| Q2 24 | $483.7M | $7.9B | ||
| Q1 24 | $492.1M | $7.9B |
| Q4 25 | — | 0.36× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.61× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $79.2M |
| Free Cash FlowOCF − Capex | $-1.8M | $74.3M |
| FCF MarginFCF / Revenue | -2.9% | 117.0% |
| Capex IntensityCapex / Revenue | 1.6% | 7.8% |
| Cash ConversionOCF / Net Profit | — | 2.94× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $115.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $79.2M | ||
| Q3 25 | $-3.9M | $10.9M | ||
| Q2 25 | $108.0K | $19.5M | ||
| Q1 25 | $-125.0K | $15.2M | ||
| Q4 24 | $2.0M | $6.4M | ||
| Q3 24 | $13.2M | $32.3M | ||
| Q2 24 | $6.2M | $15.9M | ||
| Q1 24 | $4.0M | $6.5M |
| Q4 25 | $-1.8M | $74.3M | ||
| Q3 25 | $-4.6M | $9.4M | ||
| Q2 25 | $-1.5M | $18.1M | ||
| Q1 25 | $-974.0K | $14.1M | ||
| Q4 24 | $1.1M | $1.3M | ||
| Q3 24 | $12.2M | $31.0M | ||
| Q2 24 | $5.2M | $15.1M | ||
| Q1 24 | $3.4M | $5.4M |
| Q4 25 | -2.9% | 117.0% | ||
| Q3 25 | -8.7% | 16.1% | ||
| Q2 25 | -3.2% | 27.3% | ||
| Q1 25 | -2.3% | 20.5% | ||
| Q4 24 | 1.9% | 2.4% | ||
| Q3 24 | 23.7% | 53.1% | ||
| Q2 24 | 11.0% | 27.1% | ||
| Q1 24 | 7.6% | 10.1% |
| Q4 25 | 1.6% | 7.8% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 3.5% | 2.1% | ||
| Q1 25 | 2.0% | 1.6% | ||
| Q4 24 | 1.6% | 9.6% | ||
| Q3 24 | 2.0% | 2.2% | ||
| Q2 24 | 2.3% | 1.5% | ||
| Q1 24 | 1.3% | 2.2% |
| Q4 25 | — | 2.94× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.64× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 1.78× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 0.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
HBNC
Segment breakdown not available.
